Screener
Amneal Pharmaceuticals, Inc. AMRX AvKARE — SG&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Three Months Ended June 30, 2026 | Affordable Medicines (1) | Specialty | Av KARE | Corporateand Other | Total Company |
|---|---|---|---|---|---|
| Net revenue | $489,913 | $149,295 | $156,989 | — | $796,197 |
| Cost of goods sold | 282,684 | 48,265 | 130,740 | — | 461,689 |
| Gross profit | 207,229 | 101,030 | 26,249 | — | 334,508 |
| Selling, general and administrative | 42,367 | 40,095 | 16,913 | 49,347 | 148,722 |
| Research and development | 33,023 | 5,994 | — | — | 39,017 |
| Intellectual property legal development expenses | 2,002 | 85 | — | — | 2,087 |
| Acquisition costs | — | — | — | 7,600 | 7,600 |
| Restructuring and other charges | — | — | — | 554 | 554 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s avkare — SG&A?
- Amneal Pharmaceuticals, Inc. (AMRX) reported avkare — SG&A of $16.91M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s avkare — SG&A changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s avkare — SG&A increased by 12.2% year-over-year, from $15.08M to $16.91M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s avkare — SG&A?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s avkare — SG&A has grown at a 2.2% compound annual growth rate (CAGR), from $57.92M to $63.18M.
- What does avkare — SG&A mean?
- Encompasses the indirect operating expenses required to support the AvKARE segment, including sales force compensation, marketing, legal, and general corporate overhead. This metric is used to assess the operational leverage and cost discipline of the segment's management team.
Ask your AI about Amneal Pharmaceuticals, Inc.'s avkare — sg&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude